HER2 overexpression, though less frequent than in MPD, is significant in EMPD, particularly in invasive cases, where it is associated with deeper tumor invasion and lymph node metastasis, marking a more aggressive disease course [24,60]. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.